User profiles for Massimo Papale

Massimo Papale, Ph.D.

University of Bari, Italy
Verified email at unifg.it
Cited by 877

[HTML][HTML] A systems biology overview on human diabetic nephropathy: from genetic susceptibility to post-transcriptional and post-translational modifications

F Conserva, L Gesualdo, M Papale - Journal of diabetes research, 2016 - hindawi.com
Diabetic nephropathy (DN), a microvascular complication occurring in approximately 20–40%
of patients with type 2 diabetes mellitus (T2DM), is characterized by the progressive …

Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy

M Papale, S Di Paolo, R Magistroni… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE Chronic renal insufficiency and/or proteinuria in type 2 diabetes may stem from
chronic renal diseases (CKD) other than classic diabetic nephropathy in more than one-third …

[HTML][HTML] Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of kidney fibrosis in diabetic nephropathy

…, F Pesce, C Divella, A Oranger, M Papale… - Scientific reports, 2019 - nature.com
Diabetic Nephropathy (DN) is a chronic complication of diabetes and the primary cause of
end stage renal disease. Differential diagnosis for DN requires invasive histological …

Urine protein profile of IgA nephropathy patients may predict the response to ACE‐inhibitor therapy

MT Rocchetti, M Centra, M Papale, G Bortone… - …, 2008 - Wiley Online Library
This study was aimed at the search of urinary biomarkers which might help to predict the
clinical response of IgA nephropathy (IgAN) patients to angiotensin converting enzyme …

[HTML][HTML] Understanding mechanisms of RKIP regulation to improve the development of new diagnostic tools

M Papale, GS Netti, G Stallone, E Ranieri - Cancers, 2022 - mdpi.com
Simple Summary Raf Kinase Inhibitor protein is a protein that governs multiple intracellular
signalling involved primarily in the progression of tumours and the development of …

[HTML][HTML] Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma

M Papale, G Vocino, G Lucarelli, M Rutigliano… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Clear cell Renal Cell Carcinoma (ccRCC) causes over 13,000 deaths each year, and about
20,000 new cases/year in Europe. In most cases, the causes are unknown and, most …

Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

M Papale, S Di Paolo, G Vocino, MT Rocchetti… - Journal of …, 2014 - Springer
Diabetic nephropathy (DN) has become the most frequent cause of chronic kidney disease
worldwide due to the constant increase of the incidence of type 2 diabetes mellitus in …

[HTML][HTML] Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol

KM Gooding, C Lienczewski, M Papale, N Koivuviita… - BMC nephrology, 2020 - Springer
Background Diabetic kidney disease (DKD) remains one of the leading causes of
premature death in diabetes. DKD is classified on albuminuria and reduced kidney function (estimated …

Hypertension in high school students: genetic and environmental factors: the HYGEF study

…, S Bianchi, GB Pertosa, MT Rocchetti, M Papale… - …, 2020 - Am Heart Assoc
Hypertension and obesity in the young population are major risk factors for renal and
cardiovascular events, which could arise in adulthood. A candidate-gene approach was applied in …

Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy

MT Rocchetti, M Papale, AM d'Apollo… - Clinical Journal of the …, 2013 - journals.lww.com
Results Two proteins, with 21,598 and 23,458 m/z, were significantly decreased in IgA
nephropathy and identified as Perlecan laminin G-like 3 peptide and Ig κ light chains, respectively…